Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Enterprise Value (EV)

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Current Enterprise Value (EV)

Celgene Corp., current enterprise value calculation

Microsoft Excel
Current share price (P)
No. shares of common stock outstanding
US$ in millions
Common equity (market value)1
Add: Preferred stock, $.01 par value per share; none outstanding (per books)
Total equity
Add: Short-term borrowings and current portion of long-term debt (per books)
Add: Long-term debt, net of discount, excluding current portion (per books)
Total equity and debt
Less: Cash and cash equivalents
Less: Debt securities available-for-sale
Less: Equity investments with readily determinable fair values
Less: Marketable securities available-for-sale
Enterprise value (EV)

Based on: 10-K (reporting date: 2018-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×


Historical Enterprise Value (EV)

Celgene Corp., EV calculation

Microsoft Excel
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Share price1, 2
No. shares of common stock outstanding1
US$ in millions
Common equity (market value)3
Add: Preferred stock, $.01 par value per share; none outstanding (book value)
Total equity
Add: Short-term borrowings and current portion of long-term debt (book value)
Add: Long-term debt, net of discount, excluding current portion (book value)
Total equity and debt
Less: Cash and cash equivalents
Less: Debt securities available-for-sale
Less: Equity investments with readily determinable fair values
Less: Marketable securities available-for-sale
Enterprise value (EV)

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Celgene Corp. Annual Report.

3 2018 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×

Equity Trends
Common equity, as well as total equity, demonstrated a general downward trend over the five-year period. Starting at approximately 98.8 billion US dollars at the end of 2014, equity decreased significantly to 77.8 billion in 2015, saw a rebound to 89.9 billion in 2016, then declined steadily to reach 62.9 billion by the end of 2018. This pattern indicates a fluctuating but overall reduction in shareholder equity, with a notable drop in the last two years under review.
Total Equity and Debt Trends
Total equity and debt followed a similar pattern to equity alone but with lower absolute values, reflecting the combined financing from both equity holders and debt providers. The figure started at 105.7 billion in 2014, decreased to 92.1 billion in 2015, increased again to 104.2 billion in 2016, then declined to 87.4 billion in 2017 and further to 83.3 billion in 2018. This suggests that the company maintained a substantial level of debt alongside its equity financing, but the total capital base reduced somewhat over time.
Enterprise Value (EV) Trends
Enterprise value, representing the total company valuation, showed variability consistent with the trends in equity and total capital. Starting from 98.1 billion in 2014, EV declined to 85.5 billion in 2015, rose back to 96.3 billion in 2016, then dropped to 75.4 billion in 2017 before slightly increasing to 77.2 billion in 2018. This fluctuation indicates market valuation volatility and possibly changes in debt levels, earnings prospects, or investor sentiment during the period.
Overall Observations
The financial data displays a cyclical trend with a peak around 2014 and 2016 followed by declines towards 2017 and 2018 across equity, total capital, and enterprise value metrics. The decline in common equity and enterprise value in the later years may reflect operational challenges, changes in market conditions, or strategic decisions impacting valuation. The partial recovery in 2016 suggests some positive developments that were not sustained. The persistent decreases in total equity, capital base, and EV toward the end of the period suggest increased financial pressures or diminished growth expectations.